196 related articles for article (PubMed ID: 35383895)
1. Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?
Alm J; Duong Y; Wienzek-Lischka S; Cooper N; Santoso S; Sachs UJ; Kiefel V; Bein G
Br J Haematol; 2022 Jul; 198(1):14-23. PubMed ID: 35383895
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
[TBL] [Abstract][Full Text] [Related]
3. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
4. FNAIT pathogenesis determined by serial analysis of three subsequent pregnancies of a woman with severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) with anti-HPA-4b and anti-HPA-5b alloantibodies in the first sibling.
Kiyokawa T; Mimura K; Nagamine K; Nakayama K; Horiuchi M; Morikawa T; Hosokawa M; Nakao M; Endo M; Kimura T; Kato H; Tomiyama Y; Kashiwagi H
Int J Hematol; 2023 Jul; 118(1):146-150. PubMed ID: 36797397
[TBL] [Abstract][Full Text] [Related]
5. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
[TBL] [Abstract][Full Text] [Related]
6. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
7. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia.
Sachs UJ; Wienzek-Lischka S; Duong Y; Qiu D; Hinrichs W; Cooper N; Santoso S; Bayat B; Bein G
Br J Haematol; 2020 May; 189(4):751-759. PubMed ID: 31997312
[TBL] [Abstract][Full Text] [Related]
8. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
[TBL] [Abstract][Full Text] [Related]
9. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.
Cook TJ; Qiu CC; Dickinson JE
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):321-6. PubMed ID: 22510050
[TBL] [Abstract][Full Text] [Related]
10. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
Uhrynowska ME; Dębska M; Guz K; Orzińska A; Wróbel A; Maślanka K; Dębski R; Brojer E
Ginekol Pol; 2015 Jan; 86(1):62-6. PubMed ID: 25775877
[TBL] [Abstract][Full Text] [Related]
11. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
[TBL] [Abstract][Full Text] [Related]
12. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
[TBL] [Abstract][Full Text] [Related]
13. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
14. An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study.
Geisen C; Kjaer M; Fleck E; Skogen B; Armstrong R; Behrens F; Bhagwagar Z; Braeuninger S; Mortberg A; Olsen KJ; Gastón Schäfer SM; Walter C; Seifried E; Wikman A; Kjeldsen-Kragh J; Koehm M
J Thromb Haemost; 2023 Apr; 21(4):838-849. PubMed ID: 36696185
[TBL] [Abstract][Full Text] [Related]
15. Fetal and neonatal alloimmune thrombocytopenia: a late or missed diagnosis disease in fetal and perinatal health-care settings.
Blanco S; Vega LC; Carrizo LH; Culasso JM; Gallego SV
J Matern Fetal Neonatal Med; 2022 Jan; 35(2):263-268. PubMed ID: 31973628
[TBL] [Abstract][Full Text] [Related]
16. Fetal and neonatal alloimmune thrombocytopenia.
van den Akker ES; Oepkes D
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686
[TBL] [Abstract][Full Text] [Related]
17. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study.
Refsum E; Håkansson S; Mörtberg A; Wikman A; Westgren M
Transfusion; 2018 Jan; 58(1):223-231. PubMed ID: 29119564
[TBL] [Abstract][Full Text] [Related]
18. Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.
Husebekk A; El Ekiaby M; Gorgy G; Killie MK; Uhlin-Hansen C; Salma W; Navarrete C; El Afandi M; Skogen B; Ahlen MT
Transfus Apher Sci; 2012 Dec; 47(3):277-82. PubMed ID: 22640833
[TBL] [Abstract][Full Text] [Related]
19. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
Bonstein L; Haddad N
Thromb Res; 2017 Mar; 151 Suppl 1():S100-S102. PubMed ID: 28262226
[TBL] [Abstract][Full Text] [Related]
20. HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk.
Winkelhorst D; de Vos TW; Kamphuis MM; Porcelijn L; Lopriore E; Oepkes D; van der Schoot CE; de Haas M
BMJ Open; 2020 Jul; 10(7):e034071. PubMed ID: 32690731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
